Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:59 AM
Ignite Modification Date:
2025-12-25 @ 12:59 AM
NCT ID:
NCT02689193
Eligibility Criteria:
A. Travel clinic Institute of Tropical Medicine (ITM) Antwerp
Inclusion Criteria:
Adults (≥ 18 years) and children aged 3 years to 18 years with (suspicion of) fever and:
1. presenting at ITM travel clinic with history of fever (axillary T° ≥ 38°C) and/or chills/rigor and sweats within 3 days prior to consultation
2. presenting at ITM travel clinic for routine check-up ("apparently healthy")
3. with recent (\< 2 weeks) stay in tropical country
Exclusion Criteria:
Refusal to participate
B. Sihanouk Hospital Center of HOPE (SHCH)
Inclusion Criteria:
Adults (≥ 18 years) with (suspicion of) fever and:
1\. Presenting at the in- and outpatient department of SHCH with a history of fever (axillary T≥ 38°C) and/or/chills/rigor and sweats within 3 days prior to consultation
Exclusion Criteria:
1. Refusal to participate
2. Not able to give informed consent
Inclusion Criteria:
Adults (≥ 18 years) and children aged 2 months to 18 years with (suspicion of) fever and:
1\. Blood culture request by treating physician
Exclusion Criteria:
1. Not able or willing to give informed consent
2. A hemoglobin level that is considered too low for weight and age
Inclusion Criteria:
Adults (≥ 18 years) and children aged 2 months to 18 years with (suspicion of) fever and:
1\. Blood culture request by treating physician
Exclusion Criteria:
1. Not able or willing to give informed consent
2. A hemoglobin level that is considered too low for weight and age
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
2 Months
Study:
NCT02689193
Study Brief:
Protocol Section:
NCT02689193